Pamela Garzone
CIK: 0001974756
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cue Biopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 9, 2026CUE
Cue Biopharma, Inc.
Award(A)Direct18.9K shares- - Jul 9, 2026CUE
Cue Biopharma, Inc.
Award(A)Direct21.8K shares- - Jan 2, 2026CUE
Cue Biopharma, Inc.
Award(A)DirectStock Option (right to buy)
24.4K shares- - Jan 2, 2025CUE
Cue Biopharma, Inc.
Award(A)DirectStock Option (right to buy)
24.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | CUE Cue Biopharma, Inc. | Award(A) | 18,900 | - | $0 | Direct |
| Jul 9, 2026 | CUE Cue Biopharma, Inc. | Award(A) | 21,800 | - | $0 | Direct |
| Jan 2, 2026 | CUE Cue Biopharma, Inc. | Award(A) Stock Option (right to buy) | 24,400 | - | - | Direct |
| Jan 2, 2025 | CUE Cue Biopharma, Inc. | Award(A) Stock Option (right to buy) | 24,400 | - | - | Direct |
1-4 of 4 transactions
About Garzone Pamela
Garzone Pamela (SEC CIK 0001974756) files insider reports with the SEC as Director of Cue Biopharma, Inc. (CUE).
Signal8 holds 4 ownership filings by Garzone Pamela, all Form 4s, filed between Jan 3, 2025 and Aug 28, 2026. Those filings report 4 transactions, from Jan 2, 2025 to Jul 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Garzone Pamela's filings is in BOSTON, MA.
Recent filings by Garzone Pamela
Other insiders filing for Cue Biopharma, Inc. (CUE)
- Ray Sumita, Chief Legal Compliance Officer
- Meluzio Michael Vincent, VP, Prin. Accounting Officer
- Lin Shao-Lee, Chief Executive Officer
- Sarraf Pasha, Director
- Ahlers James M, Chief Financial Officer
- Borie Dominique Christian, Chief Medical Officer